SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-017634
Filing Date
2024-02-28
Accepted
2024-02-27 19:01:22
Documents
15
Period of Report
2024-02-27
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0200827-8k_60degree.htm   iXBRL 8-K 28388
  Complete submission text file 0001213900-24-017634.txt   251514

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE sxtp-20240227.xsd EX-101.SCH 3846
3 XBRL DEFINITION FILE sxtp-20240227_def.xml EX-101.DEF 27132
4 XBRL LABEL FILE sxtp-20240227_lab.xml EX-101.LAB 37438
5 XBRL PRESENTATION FILE sxtp-20240227_pre.xml EX-101.PRE 25753
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0200827-8k_60degree_htm.xml XML 5892
Mailing Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036
Business Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036 202-327-5422
60 DEGREES PHARMACEUTICALS, INC. (Filer) CIK: 0001946563 (see all company filings)

IRS No.: 452406880 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41719 | Film No.: 24689266
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)